Budget Congruency Review 

PIs conducting any research involving privately-owned animals are required by the CVM to have the associated study budget reviewed and approved by the BBVCTO. The budget congruency review must happen BEFORE a PI self-funded study or a proposal is submitted to the sponsor or funding agency, and BEFORE a contract is signed with an industry sponsor. 

PLEASE SUBMIT THIS REQUEST AT LEAST 10 BUSINESS DAYS PRIOR TO THE GRANT SUBMISSION DEADLINE. 

Request BBVCTO services 

This is to ensure that budgets are formulated in accordance with hospital fees, research discounts, and other college requirements and are congruent with both the study protocol and study calendar. It is strongly recommended that PIs reach out to the BBVCTO staff early in the process of study desing to avoid delays during the congruency review. Budgets funded by internal sources should be submitted prior to initiating the IACUC review process. 

PIs can request a Budget Congruency Review by submitting the following information: 

  • Protocol
  • Calendar of events
  • Consent form
  • Preliminary budget

PIs can download templates of protocols, calendar of events, informed consent form, budgets, and sample collection SOPs here

BBVCTO staff will review the budget to ensure it is congruent with what was proposed in the grant, consent form and calendar of events/study protocol. Comments may be provided. Additional information may be requested if clarifcation is needed. 

Following budget approval, PIs can submit the CVM approved budget to the sponsor for approval. 

Key Points
 

  • Any NEW clinical trial requires a budget congruency review. PIs must submit this request at least 10 business days prior to the grant submission deadline. 
  • Failure of the PI to initiate a budget review via the mechanism detailed above will result in delayed grant submission or commencement of a self-funded study. 
  • Any ongoing study that needs protocol changes or if the budget has been altered (AMENDMENT), requires a new budget congruency review and a new approval by the sponsor. The agreement for the clinical trials will also need to be amended with the new budget.